Article info

Download PDFPDF

Original article
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland

Authors

  1. Correspondence to Professor Axel Finckh; Axel.finckh{at}hcuge.ch
View Full Text

Citation

Finckh A, Tellenbach C, Herzog L on behalf of the physicians and patients of the SCQM, et al
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland

Publication history

  • Received January 8, 2020
  • Revision received February 11, 2020
  • Accepted March 2, 2020
  • First published May 7, 2020.
Online issue publication 
May 29, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.